| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.91▼ | 2.91▼ | 2.91▼ | 2.74▼ | 2.90▼ |
| MA10 | 2.88▼ | 2.90▼ | 2.90▼ | 2.87▼ | 3.09▼ |
| MA20 | 3.06▼ | 3.10▼ | 3.11▼ | 2.91▼ | 3.34▼ |
| MA50 | 3.36▼ | 3.47▼ | 3.49▼ | 3.16▼ | N/A |
| MA100 | 3.58▼ | 3.50▼ | 3.47▼ | 3.37▼ | N/A |
| MA200 | 3.67▼ | 3.43▼ | 3.29▼ | 3.08▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.028▼ | -0.028▼ | -0.025▼ | -0.121▼ |
| RSI | 33.531▼ | 34.034▼ | 34.220▼ | 34.882▼ | 37.695▼ |
| STOCH | 26.904 | 20.884 | 20.884 | 25.668 | 16.138▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -84.835▼ | -92.895▼ |
| CCI | -185.599▼ | -167.047▼ | -167.047▼ | -150.266▼ | -172.771▼ |
|
Monday, September 28, 2026 01:00 AM
NCEL-101 combines NewcelX’s enriched stem-cell-derived pancreatic islet cells with Eledon Pharmaceuticals’ investigational anti-CD40L antibody, tegoprubart, as part of a proposed immunomodulatory ...
|
|
Friday, July 31, 2026 06:00 AM
Private Financing Reflects Strong Investor Confidence and Supports Advancement of Lead Type 1 Diabetes Program Following Successful FDA Pre-IND Meeting ZURICH, Switzerland, July 31, 2026 (GLOBE ...
|
|
Wednesday, July 15, 2026 06:00 AM
ZURICH, July 15, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. ("NewcelX"; Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, today announced that the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/26 | 2.77 | 3.14 | 2.3608 | 2.50 | 23,099 |
| 15/10/26 | 2.61 | 2.90 | 2.61 | 2.85 | 5,647 |
| 14/10/26 | 2.80 | 2.87 | 2.61 | 2.61 | 9,296 |
| 13/10/26 | 2.83 | 3.2787 | 2.80 | 2.84 | 5,411 |
| 12/10/26 | 2.96 | 2.96 | 2.9039 | 2.9039 | 1,104 |
| 09/10/26 | 3.02 | 3.0819 | 3.02 | 3.045 | 1,326 |
| 08/10/26 | 2.925 | 3.1101 | 2.89 | 3.11 | 7,303 |
| 07/10/26 | 3.04 | 3.04 | 2.975 | 3.035 | 1,463 |
| 06/10/26 | 2.99 | 3.20 | 2.9159 | 2.9607 | 7,211 |
| 05/10/26 | 2.824 | 2.86 | 2.82 | 2.86 | 4,087 |
|
|
||||
|
|
||||
|
|